332 related articles for article (PubMed ID: 22086675)
1. Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling.
Raina K; Agarwal C; Agarwal R
Mol Carcinog; 2013 Mar; 52(3):195-206. PubMed ID: 22086675
[TBL] [Abstract][Full Text] [Related]
2. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
[TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
Singh RP; Gu M; Agarwal R
Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
[TBL] [Abstract][Full Text] [Related]
4. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
[TBL] [Abstract][Full Text] [Related]
5. Silibinin modulates TNF-α and IFN-γ mediated signaling to regulate COX2 and iNOS expression in tumorigenic mouse lung epithelial LM2 cells.
Tyagi A; Agarwal C; Dwyer-Nield LD; Singh RP; Malkinson AM; Agarwal R
Mol Carcinog; 2012 Oct; 51(10):832-42. PubMed ID: 21882257
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
7. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules.
Velmurugan B; Gangar SC; Kaur M; Tyagi A; Deep G; Agarwal R
Pharm Res; 2010 Oct; 27(10):2085-97. PubMed ID: 20628792
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-inflammatory effects of silibinin and thymol combination on LPS-induced RAW264.7 cells by inhibition of NF-κB and MAPK activation.
Chen J; Li DL; Xie LN; Ma YR; Wu PP; Li C; Liu WF; Zhang K; Zhou RP; Xu XT; Zheng X; Liu X
Phytomedicine; 2020 Nov; 78():153309. PubMed ID: 32890914
[TBL] [Abstract][Full Text] [Related]
9. Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells.
Kim BR; Seo HS; Ku JM; Kim GJ; Jeon CY; Park JH; Jang BH; Park SJ; Shin YC; Ko SG
Inflamm Res; 2013 Nov; 62(11):941-50. PubMed ID: 24045679
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.
Chittezhath M; Deep G; Singh RP; Agarwal C; Agarwal R
Mol Cancer Ther; 2008 Jul; 7(7):1817-26. PubMed ID: 18644994
[TBL] [Abstract][Full Text] [Related]
11. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
Singh RP; Dhanalakshmi S; Mohan S; Agarwal C; Agarwal R
Mol Cancer Ther; 2006 May; 5(5):1145-53. PubMed ID: 16731746
[TBL] [Abstract][Full Text] [Related]
12. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft.
Kaur M; Velmurugan B; Tyagi A; Deep G; Katiyar S; Agarwal C; Agarwal R
Mol Cancer Ther; 2009 Aug; 8(8):2366-74. PubMed ID: 19638451
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
[TBL] [Abstract][Full Text] [Related]
14. Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries.
Raina K; Agarwal C; Wadhwa R; Serkova NJ; Agarwal R
Autophagy; 2013 May; 9(5):697-713. PubMed ID: 23445752
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
[TBL] [Abstract][Full Text] [Related]
16. Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.
Liu YC; Tsai JJ; Weng YS; Hsu FT
Biomed Pharmacother; 2020 Aug; 128():110319. PubMed ID: 32502841
[TBL] [Abstract][Full Text] [Related]
17. Silibinin treatment prevents endotoxin-induced uveitis in rats in vivo and in vitro.
Chen CL; Chen JT; Liang CM; Tai MC; Lu DW; Chen YH
PLoS One; 2017; 12(4):e0174971. PubMed ID: 28376126
[TBL] [Abstract][Full Text] [Related]
18. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of nuclear factor-kappa B (NF-kappaB) pathway by silibinin in human monocytes challenged with Paracoccidioides brasiliensis.
Bannwart CF; Nakaira-Takahagi E; Golim MA; de Medeiros LT; Romão M; Weel IC; Peraçoli MT
Life Sci; 2010 Jun; 86(23-24):880-6. PubMed ID: 20398679
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3.
Tyagi A; Singh RP; Ramasamy K; Raina K; Redente EF; Dwyer-Nield LD; Radcliffe RA; Malkinson AM; Agarwal R
Cancer Prev Res (Phila); 2009 Jan; 2(1):74-83. PubMed ID: 19139021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
